iBio
IBIO
#9703
Rank
โ‚น6.80 B
Marketcap
โ‚น137.08
Share price
-3.40%
Change (1 day)
100.70%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): -โ‚น131.39

According to iBio's latest financial reports the company's current EPS (TTM) is -โ‚น148.66. an increase over its 2024 EPS that were of -โ‚น627.46.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025-โ‚น168.93-73.08%
2024-โ‚น627.46-93.88%
2023-โ‚น10,251-8.14%
2022-โ‚น11,15992.67%
2021-โ‚น5,792-80.33%
2020-โ‚น29,442-35.11%
2019-โ‚น45,370-38.96%
2018-โ‚น74,330-6.1%
2017-โ‚น79,15736.67%
2016-โ‚น57,92033.33%
2015-โ‚น43,44050%
2014-โ‚น28,960-53.85%
2013-โ‚น62,746-7.14%
2012-โ‚น67,573-64.1%
2011-โ‚น1,88,23877.27%
2010-โ‚น1,06,186144.44%
2009-โ‚น43,44012.93%
2008-โ‚น38,46712.2%
2007-โ‚น34,284

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น843.34-667.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-โ‚น50.20-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น984.63 562.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น136.11-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA